📰 Nasdaq Ctic News
Nasdaq Ctic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Ctic. Real-time updates on events, politics, business and more.
July 24, 2023
Equities research analysts at StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Free Report) in a research note issued to investors on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on CTIC. Stifel Nicolaus cut CTI BioPharma from […]
July 17, 2023
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the stock. TD Cowen reduced their target price on shares of CTI BioPharma from $10.00 to $8.00 […]
July 17, 2023
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research report report published on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. CTIC has been the subject of several other research reports. SVB Securities lowered shares of CTI BioPharma from an outperform rating to a […]
June 28, 2023
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on CTIC. Stifel Nicolaus cut shares of CTI BioPharma from a buy rating to […]
June 22, 2023
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages also recently issued reports on CTIC. JMP Securities downgraded CTI BioPharma from an outperform rating to a […]
June 16, 2023
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average trading volume of 5,510,000 shares, the short-interest ratio is […]
June 15, 2023
CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 11,270,000 shares, an increase of 39.5% from the May 15th total of 8,080,000 shares. Based on an average daily trading volume, of 5,510,000 shares, […]
June 6, 2023
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research report report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on CTIC. TD Cowen dropped their price target on shares of CTI BioPharma from […]
June 2, 2023
CTI BioPharma (NASDAQ: CTIC) recently received a number of ratings updates from brokerages and research firms: 5/26/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/18/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/16/2023 […]
May 29, 2023
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a report published on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on CTIC. Needham & Company LLC cut CTI BioPharma from a buy rating to a hold […]